A New Jersey-based pharmaceutical company has agreed to pay $25 million for allegedly engaging in a price-fixing scheme for a generic cholesterol drug.
“Illegal collaboration on the price or supply of drugs increases costs both to federal health care programs and beneficiaries,” said the Department of Justice’s (DOJ) Principal Deputy Assistant Attorney General Brian Boynton. “The department will use every tool at its disposal to prevent such conduct and to protect these taxpayer-funded programs from abuse.”
The DOJ alleged that between 2013 and 2015, Glenmark Pharmaceuticals Inc., in Mahwah, New Jersey, violated the federal Anti-Kickback Statute.
This statute prohibits companies from making or receiving payments in exchange for the purchase or sale of drugs funded by federal health care plans.
The statute was written to prevent “improper financial incentives” from compromising health care costs, the DOJ said. […]
— Read More: www.theepochtimes.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
